PARP1 and cancer: Understanding the immunomodulatory roles of PARP-1 and PARP-2 may provide invaluable clues for the rational development and exploitation of more selective anti-cancer PARP inhibitor drugs, both as new monotherapeutic approaches and in combinations with immunotherapy.